Nursing Experience of Inhalation Ambroxol and Budesonide in the Treatment of Acute
Exacerbation of Chronic Obstructive Pulmonary Disease
Abstract: Objective: To investigate the nursing efficacy of inhalation ambroxol and budesonide in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: 68 patients diagnosed as AECOPD were enrolled during February 2014-March 2014 in department of Respiratory and Critical Care Medicine, including 36 men and 32 women, aged 58 - 82 years old. The subjects were randomly divided into the ambroxol and budesonide inhalation group (35 cases) and the brine inhalation group (33 cases). Nurses will bring substance to the patients’ bedside, check, explain to the patient to get cooperation and instruct the patient to take a comfortable position. The liquid drugs were injected into the atomizer, which was connected to the oxygen inhalation device. The oxygen flow was adjusted to 2 - 4 L/min. Patients handheld the jet tube into the mouth, closed lips, inhaled deeply to allow liquid to fully achieve the bronchi and lungs and held breath 1 - 2 seconds. The whole process lasted 10 - 20 minutes. When the treatment completed, nurses turned off the oxygen, removed the atomizer, cleaned up with things which would be disinfected. Patients received the treatment once in the morning and in the afternoon, usually before meals, being conductive to expectoration, or avoiding specific drug-induced nausea and vomiting. The best position was sitting or lying, in favor of inhalation liquid drug deposited into the bronchioles and alveoli. After the inhalation therapy, nurses shot back orderly from the bottom to up and the inside to outward and encouraged patients to take a deep breath and vigorously cough up the phlegm and observed the sputum traits, color and volume changes in order to evaluate the efficacy of the treatment. Comparison between the groups of data was evaluated using t-test. Results: sputum reduced time and hospitalization time of patients in the observation group were significantly lower than the control group. The difference was statistically significant (p < 0. 01). Conclusion: Ambroxol hydrochloride budesonide inhalation was better than the saline inhalation, which has an important clinical significance.
文章引用: 邱 丽 , 杜 娟 , 严 馨 (2014) 盐酸氨溴索联合布地奈德雾化吸入治疗慢性阻塞性肺疾病急性加重期的护理体会。 护理学， 3， 106-109. doi: 10.12677/NS.2014.34023
 纪妮 (2010) 氨溴索雾化吸入治疗慢性阻塞性肺病的护理体会. 中国中医药资讯, 32, 78.
 敬仁芝, 罗婷 (2011) 喘可治联合盐酸氨溴索雾化吸入治疗老年慢性阻塞性肺疾病急性期的临床观察. 全科护理, 26, 2354-2355.
 邹晓华, 蒋颖超, 王丹等 (2011) 布地奈德联合沙汀胺醇雾化吸入对慢性阴塞性肺疾病急性加重期的治疗作用. 中国现代医学杂志, 24, 3044-3046.